These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 11440366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity.
    Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA.
    Diabetes; 2001 Jun; 50(6):1351-62. PubMed ID: 11375336
    [Abstract] [Full Text] [Related]

  • 4. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA.
    Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
    [Abstract] [Full Text] [Related]

  • 5. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.
    Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA.
    Diabetes; 2000 Feb; 49(2):272-83. PubMed ID: 10868944
    [Abstract] [Full Text] [Related]

  • 6. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.
    Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA.
    Diabetes; 2002 Feb; 51(2):301-10. PubMed ID: 11812736
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [Abstract] [Full Text] [Related]

  • 8. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [Abstract] [Full Text] [Related]

  • 9. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
    Pereira Arias AM, Bisschop PH, Ackermans MT, Endert E, Romijn JA, Sauerwein HP.
    Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
    [Abstract] [Full Text] [Related]

  • 10. Lipid-dependent control of hepatic glycogen stores in healthy humans.
    Stingl H, Krssák M, Krebs M, Bischof MG, Nowotny P, Fürnsinn C, Shulman GI, Waldhäusl W, Roden M.
    Diabetologia; 2001 Jan; 44(1):48-54. PubMed ID: 11206411
    [Abstract] [Full Text] [Related]

  • 11. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
    Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA.
    Diabetologia; 2002 Oct; 45(10):1410-5. PubMed ID: 12378382
    [Abstract] [Full Text] [Related]

  • 12. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects.
    Kiwanuka E, Barazzoni R, Tessari P.
    Diabetes Nutr Metab; 2001 Dec; 14(6):315-24. PubMed ID: 11853363
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.
    Rigalleau V, Beauvieux MC, Gallis JL, Gin H, Schneiter P, Tappy L.
    Diabetes Metab; 2010 Jun; 36(3):234-9. PubMed ID: 20303815
    [Abstract] [Full Text] [Related]

  • 15. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
    Nielsen MF, Wise S, Dinneen SF, Schwenk WF, Basu A, Rizza RA.
    Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
    [Abstract] [Full Text] [Related]

  • 16. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U, Müller R, Berger W.
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [Abstract] [Full Text] [Related]

  • 17. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I, Jenssen T.
    Scand J Clin Lab Invest; 2005 Sep; 65(4):307-20. PubMed ID: 16076686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.